AI Analysis

Log in to generate an AI summary for this stock.

Log in to generate a MOAT report for this stock.

Log in to generate an earnings report for this stock.

Log in to generate an operating leverage report for this stock.

Log in to generate a management report for this stock.

Log in to generate a valuation report for this stock.

West Pharmaceutical Services, Inc.

$346.23 +$69.83 (+25.26%)
NYSE · 11 Sep 2026 20:02 UTC
Previous Close
$344.25
Day Range
$341.68$351.96
Year Range
$223.83$386
Market Cap
24.37B
AVG Volume
710.73K
Trailing/Forward PE
43.99/34.65
PEG ratio
3.86
Dividend Yield
0.25%
Next Earnings Date
2026-10-22
Primary Exchange
New York Stock ExchangeUS
Revenue (USD)
01B2B3B4B2016201720182019202020212022202320242025
WST Revenue (USD) by year
PeriodRevenue (USD)
20253.07B
20242.89B
20232.95B
20222.89B
20212.83B
20202.15B
20191.84B
20181.72B
20171.6B
20161.51B
Net Income (USD)
0200M400M600M800M2016201720182019202020212022202320242025
WST Net Income (USD) by year
PeriodNet Income (USD)
2025493.7M
2024492.7M
2023593.4M
2022585.9M
2021661.8M
2020346.2M
2019241.7M
2018206.9M
2017148.2M
2016143.5M
Operating Income (USD)
0200M400M600M800M2016201720182019202020212022202320242025
WST Operating Income (USD) by year
PeriodOperating Income (USD)
2025616.9M
2024596.2M
2023716.5M
2022760.1M
2021754.6M
2020421.7M
2019297.3M
2018244.8M
2017220.9M
2016198.4M
EBITDA (USD)
0250M500M750M1B2016201720182019202020212022202320242025
WST EBITDA (USD) by year
PeriodEBITDA (USD)
2025776M
2024744.6M
2023844.1M
2022807.7M
2021879.6M
2020519M
2019403.2M
2018353.2M
2017326.1M
2016313.3M
Cash Flows (USD)
0200M400M600M2016201720182019202020212022202320242025
WST Cash Flows (USD) by year
PeriodCash Flows (USD)
2025468.9M
2024276.4M
2023414.5M
2022439.4M
2021330.6M
2020298.1M
2019240.8M
2018183.9M
2017132.5M
201649.2M
EPS (USD)
02.557.5102016201720182019202020212022202320242025
WST EPS (USD) by year
PeriodEPS (USD)
20256.8
20246.69
20237.88
20227.73
20218.7
20204.58
20193.2
20182.75
20171.96
20161.92
Expenses (USD)
0200M400M600M800MR&DSG&ACapex2016201720182019202020212022202320242025
WST Expenses (USD) by year
PeriodExpenses (USD)
2025753.3M
2024783M
2023783.8M
2022660M
2021669M
2020516.6M
2019438M
2018407.9M
2017415M
2016446.8M
Cash & Debt (USD)
0250M500M750M1BCashLong Term DebtShort Term Debt2016201720182019202020212022202320242025
WST Cash & Debt (USD) by year
PeriodCash & Debt (USD)
2025791.3M
2024484.6M
2023853.9M
2022894.3M
2021762.6M
2020615.5M
2019439.1M
2018337.4M
2017235.9M
2016203M
Debt ratios
-0.3-0.2-0.1-020182019202020212022202320242025
WST Debt ratios by year
PeriodDebt ratios
2025-0.15
2024-0.06
2023-0.18
2022-0.22
2021-0.2
2020-0.18
2019-0.08
2018-0.12
Margins
0%20%40%60%2016201720182019202020212022202320242025
WST Margins by year
PeriodMargins
202535.89%
202434.65%
202338.35%
202239.34%
202141.34%
202035.58%
201933.03%
201831.8%
201732.16%
201633.19%
Return on Capital
0%10%20%30%2016201720182019202020212022202320242025
WST Return on Capital by year
PeriodReturn on Capital
202515.54%
202418.37%
202320.6%
202221.82%
202128.34%
202018.67%
201915.36%
201814.82%
201711.58%
201612.84%
Shares Outstanding
020M40M60M80M2016201720182019202020212022202320242025
WST Shares Outstanding by year
PeriodShares Outstanding
202572.3M
202473M
202374.1M
202274.4M
202174.5M
202074M
201974.1M
201873.9M
201774.2M
201673.2M
Dividends (USD)
00.250.50.7512017201820192020202120222023202420252026
WST Dividends (USD) by year
PeriodDividends (USD)
20260.66
20250.85
20240.81
20230.77
20220.73
20210.69
20200.65
20190.61
20180.57
20170.53
Employee Count
05K10K15K2016201720182019202020212022202320242025
WST Employee Count by year
PeriodEmployee Count
202510.8K
202410.6K
202310.6K
202210.7K
202110.06K
20209.2K
20198.2K
20187.6K
20177.3K
20167.1K
Book Value Per Share (USD)
02040602016201720182019202020212022202320242025
WST Book Value Per Share (USD) by year
PeriodBook Value Per Share (USD)
202543.93
202436.74
202338.88
202236.09
202131.35
202025.06
201921.23
201818.89
201717.25
201615.27
Total Assets (USD)
02B4B6B2016201720182019202020212022202320242025
WST Total Assets (USD) by year
PeriodTotal Assets (USD)
20254.27B
20243.64B
20233.83B
20223.62B
20213.31B
20202.79B
20192.34B
20181.59B
20171.86B
20161.72B
PE Ratio
2030405060med 39.86Dec 24Apr 25Jul 25Oct 25Feb 26May 26Sep 26
WST PE Ratio by year
PeriodPE Ratio
Sep 2643.39
Sep 2642.61
Aug 2642.3
Aug 2644.25
Aug 2643.79
Aug 2644.38
Jul 2642.73
Jul 2641.13
Jul 2647.53
Jul 2646.93
Jul 2648.52
Jun 2646.55
Jun 2643.51
Jun 2643.62
Jun 2641.72
May 2642.83
May 2641.98
May 2640.18
May 2643.24
May 2639.89
Apr 2640.62
Apr 2640.09
Apr 2637.57
Apr 2637.31
Mar 2635.64
Mar 2634.71
Mar 2634.48
Mar 2636.01
Feb 2637.25
Feb 2635.31
Feb 2636.83
Feb 2636.61
Jan 2633.98
Jan 2634.8
Jan 2638.2
Jan 2640.51
Jan 2640.64
Dec 2540.33
Dec 2540.07
Dec 2539.34
Dec 2541.21
Nov 2540.77
Nov 2539.86
Nov 2538.43
Nov 2539.85
Oct 2541.48
Oct 2543.74
Oct 2540.12
Oct 2538.81
Oct 2540.41
Sep 2538.77
Sep 2537.78
Sep 2537.58
Sep 2537.17
Aug 2536.61
Aug 2536.74
Aug 2536.5
Aug 2535.72
Aug 2535.47
Jul 2539.06
Jul 2532.73
Jul 2535.25
Jul 2534.49
Jun 2533.96
Jun 2533.49
Jun 2534.44
Jun 2534.87
May 2532.72
May 2531.9
May 2533.62
May 2533.06
May 2532.79
Apr 2533.29
Apr 2529.91
Apr 2531.22
Apr 2530.11
Mar 2532.92
Mar 2533.88
Mar 2534.09
Mar 2534.3
Feb 2534.42
Feb 2531.25
Feb 2531.29
Feb 2546.86
Jan 2549.77
Jan 2550.27
Jan 2549.01
Jan 2548.34
Jan 2548.9
Dec 2448.56
Dec 2448.29
Dec 2448.09
Dec 2446.99
Nov 2447.46
Nov 2446.13
Nov 2445.83
Nov 2447.23
Nov 2446.12
Oct 2444.87
Oct 2440.79
Free Cash Flow Yield
1%1.5%2%2.5%3%med 1.89%Dec 24Apr 25Jul 25Oct 25Feb 26May 26Sep 26
WST Free Cash Flow Yield by year
PeriodFree Cash Flow Yield
Sep 261.78%
Sep 261.82%
Aug 261.83%
Aug 261.75%
Aug 261.77%
Aug 261.74%
Jul 261.81%
Jul 261.88%
Jul 261.78%
Jul 261.8%
Jul 261.74%
Jun 261.81%
Jun 261.94%
Jun 261.93%
Jun 262.02%
May 261.97%
May 262.01%
May 262.1%
May 261.95%
May 262.12%
Apr 262.08%
Apr 262.37%
Apr 262.53%
Apr 262.55%
Mar 262.67%
Mar 262.74%
Mar 262.75%
Mar 262.64%
Feb 262.55%
Feb 262.69%
Feb 262.09%
Feb 262.11%
Jan 262.27%
Jan 262.22%
Jan 262.02%
Jan 261.9%
Jan 261.9%
Dec 251.91%
Dec 251.92%
Dec 251.96%
Dec 251.87%
Nov 251.89%
Nov 251.93%
Nov 252.01%
Nov 251.93%
Oct 251.86%
Oct 251.76%
Oct 251.76%
Oct 251.82%
Oct 251.75%
Sep 251.82%
Sep 251.87%
Sep 251.88%
Sep 251.9%
Aug 251.93%
Aug 251.92%
Aug 251.93%
Aug 251.97%
Aug 251.99%
Jul 251.81%
Jul 252.01%
Jul 251.86%
Jul 251.9%
Jun 251.93%
Jun 251.96%
Jun 251.91%
Jun 251.88%
May 252.01%
May 252.06%
May 251.95%
May 251.99%
May 252%
Apr 251.97%
Apr 251.88%
Apr 251.8%
Apr 251.86%
Mar 251.7%
Mar 251.66%
Mar 251.65%
Mar 251.64%
Feb 251.63%
Feb 251.8%
Feb 252.06%
Feb 251.37%
Jan 251.29%
Jan 251.28%
Jan 251.31%
Jan 251.33%
Jan 251.32%
Dec 241.33%
Dec 241.33%
Dec 241.34%
Dec 241.37%
Nov 241.36%
Nov 241.4%
Nov 241.4%
Nov 241.36%
Nov 241.4%
Oct 241.43%
Oct 241.67%
Price to Sales
56789med 6.47Dec 24Apr 25Jul 25Oct 25Feb 26May 26Sep 26
WST Price to Sales by year
PeriodPrice to Sales
Sep 267.37
Sep 267.24
Aug 267.18
Aug 267.51
Aug 267.44
Aug 267.54
Jul 267.26
Jul 266.99
Jul 268.01
Jul 267.91
Jul 268.18
Jun 267.84
Jun 267.33
Jun 267.35
Jun 267.03
May 267.22
May 267.07
May 266.77
May 267.29
May 266.72
Apr 266.84
Apr 266.44
Apr 266.03
Apr 265.99
Mar 265.72
Mar 265.58
Mar 265.54
Mar 265.78
Feb 265.98
Feb 265.67
Feb 266
Feb 265.97
Jan 265.54
Jan 265.67
Jan 266.23
Jan 266.6
Jan 266.62
Dec 256.57
Dec 256.53
Dec 256.41
Dec 256.72
Nov 256.64
Nov 256.5
Nov 256.26
Nov 256.49
Oct 256.76
Oct 257.13
Oct 256.61
Oct 256.39
Oct 256.66
Sep 256.39
Sep 256.23
Sep 256.19
Sep 256.12
Aug 256.03
Aug 256.05
Aug 256.01
Aug 255.89
Aug 255.84
Jul 256.44
Jul 255.28
Jul 255.69
Jul 255.56
Jun 255.48
Jun 255.4
Jun 255.56
Jun 255.63
May 255.28
May 255.15
May 255.42
May 255.33
May 255.29
Apr 255.37
Apr 255.1
Apr 255.32
Apr 255.13
Mar 255.61
Mar 255.77
Mar 255.81
Mar 255.84
Feb 255.86
Feb 255.32
Feb 255.43
Feb 258.14
Jan 258.64
Jan 258.73
Jan 258.51
Jan 258.4
Jan 258.49
Dec 248.43
Dec 248.39
Dec 248.35
Dec 248.16
Nov 248.24
Nov 248.01
Nov 247.96
Nov 248.2
Nov 248.01
Oct 247.79
Oct 247.44
EV/EBITDA
1520253035med 24.92Dec 24Apr 25Jul 25Oct 25Feb 26May 26Sep 26
WST EV/EBITDA by year
PeriodEV/EBITDA
Sep 2629.59
Sep 2629.05
Aug 2628.84
Aug 2630.18
Aug 2629.87
Aug 2630.27
Jul 2629.14
Jul 2628.04
Jul 2630.33
Jul 2629.95
Jul 2630.97
Jun 2629.7
Jun 2627.75
Jun 2627.82
Jun 2626.6
May 2627.31
May 2626.76
May 2625.61
May 2627.57
May 2625.42
Apr 2625.89
Apr 2624.9
Apr 2623.3
Apr 2623.13
Mar 2622.07
Mar 2621.48
Mar 2621.33
Mar 2622.3
Feb 2623.09
Feb 2621.86
Feb 2623.03
Feb 2622.88
Jan 2621.21
Jan 2621.73
Jan 2623.9
Jan 2625.37
Jan 2625.45
Dec 2525.26
Dec 2525.09
Dec 2524.63
Dec 2525.81
Nov 2525.53
Nov 2524.95
Nov 2524.05
Nov 2524.95
Oct 2525.98
Oct 2527.43
Oct 2525.46
Oct 2524.62
Oct 2525.64
Sep 2524.59
Sep 2523.96
Sep 2523.83
Sep 2523.57
Aug 2523.21
Aug 2523.29
Aug 2523.14
Aug 2522.64
Aug 2522.48
Jul 2524.78
Jul 2520.78
Jul 2522.39
Jul 2521.91
Jun 2521.57
Jun 2521.27
Jun 2521.87
Jun 2522.15
May 2520.77
May 2520.25
May 2521.35
May 2520.99
May 2520.82
Apr 2521.14
Apr 2519.55
Apr 2520.41
Apr 2519.68
Mar 2521.54
Mar 2522.17
Mar 2522.31
Mar 2522.45
Feb 2522.53
Feb 2520.43
Feb 2520.76
Feb 2531.2
Jan 2533.16
Jan 2533.5
Jan 2532.65
Jan 2532.2
Jan 2532.58
Dec 2432.35
Dec 2432.17
Dec 2432.04
Dec 2431.3
Nov 2431.61
Nov 2430.72
Nov 2430.51
Nov 2431.45
Nov 2430.71
Oct 2429.87
Oct 2427.83
Price/Operating Cashflow
2025303540med 28.2Dec 24Apr 25Jul 25Oct 25Feb 26May 26Sep 26
WST Price/Operating Cashflow by year
PeriodPrice/Operating Cashflow
Sep 2637.02
Sep 2636.35
Aug 2636.08
Aug 2637.75
Aug 2637.36
Aug 2637.86
Jul 2636.45
Jul 2635.09
Jul 2636.06
Jul 2635.6
Jul 2636.81
Jun 2635.32
Jun 2633.01
Jun 2633.1
Jun 2631.66
May 2632.49
May 2631.85
May 2630.49
May 2632.81
May 2630.27
Apr 2630.82
Apr 2626.22
Apr 2624.57
Apr 2624.41
Mar 2623.31
Mar 2622.7
Mar 2622.55
Mar 2623.55
Feb 2624.36
Feb 2623.1
Feb 2626.1
Feb 2625.94
Jan 2624.08
Jan 2624.66
Jan 2627.07
Jan 2628.71
Jan 2628.8
Dec 2528.58
Dec 2528.4
Dec 2527.88
Dec 2529.2
Nov 2528.89
Nov 2528.25
Nov 2527.24
Nov 2528.24
Oct 2529.39
Oct 2531
Oct 2528.91
Oct 2527.97
Oct 2529.12
Sep 2527.94
Sep 2527.23
Sep 2527.08
Sep 2526.79
Aug 2526.38
Aug 2526.48
Aug 2526.3
Aug 2525.75
Aug 2525.56
Jul 2528.15
Jul 2523.01
Jul 2524.78
Jul 2524.25
Jun 2523.88
Jun 2523.54
Jun 2524.21
Jun 2524.51
May 2523
May 2522.43
May 2523.63
May 2523.24
May 2523.05
Apr 2523.4
Apr 2522.56
Apr 2523.54
Apr 2522.7
Mar 2524.82
Mar 2525.55
Mar 2525.71
Mar 2525.86
Feb 2525.96
Feb 2523.56
Feb 2522.26
Feb 2533.33
Jan 2535.4
Jan 2535.76
Jan 2534.86
Jan 2534.38
Jan 2534.78
Dec 2434.54
Dec 2434.35
Dec 2434.21
Dec 2433.42
Nov 2433.75
Nov 2432.81
Nov 2432.6
Nov 2433.59
Nov 2432.8
Oct 2431.91
Oct 2428.46
Price to Book
5678910med 6.46Dec 24Apr 25Jul 25Oct 25Feb 26May 26Sep 26
WST Price to Book by year
PeriodPrice to Book
Sep 268.2
Sep 268.05
Aug 267.99
Aug 268.36
Aug 268.27
Aug 268.38
Jul 268.07
Jul 267.77
Jul 268.63
Jul 268.52
Jul 268.81
Jun 268.45
Jun 267.9
Jun 267.92
Jun 267.57
May 267.77
May 267.62
May 267.29
May 267.85
May 267.24
Apr 267.37
Apr 266.23
Apr 265.84
Apr 265.8
Mar 265.54
Mar 265.4
Mar 265.36
Mar 265.6
Feb 265.79
Feb 265.49
Feb 265.93
Feb 265.9
Jan 265.48
Jan 265.61
Jan 266.16
Jan 266.53
Jan 266.55
Dec 256.5
Dec 256.46
Dec 256.34
Dec 256.64
Nov 256.57
Nov 256.42
Nov 256.19
Nov 256.42
Oct 256.68
Oct 257.05
Oct 256.68
Oct 256.46
Oct 256.73
Sep 256.46
Sep 256.29
Sep 256.26
Sep 256.19
Aug 256.1
Aug 256.12
Aug 256.08
Aug 255.95
Aug 255.91
Jul 256.5
Jul 255.7
Jul 256.14
Jul 256.01
Jun 255.91
Jun 255.83
Jun 256
Jun 256.07
May 255.7
May 255.56
May 255.85
May 255.76
May 255.71
Apr 255.8
Apr 255.49
Apr 255.73
Apr 255.53
Mar 256.05
Mar 256.22
Mar 256.26
Mar 256.3
Feb 256.32
Feb 255.74
Feb 255.68
Feb 258.51
Jan 259.03
Jan 259.13
Jan 258.9
Jan 258.78
Jan 258.88
Dec 248.81
Dec 248.77
Dec 248.73
Dec 248.53
Nov 248.62
Nov 248.37
Nov 248.32
Nov 248.57
Nov 248.37
Oct 248.15
Oct 248.31
West Pharmaceutical Services, Inc.
WST
Stockpicker

Video analysis: WST

All videos

No video analysis for this stock yet. Request one from our team.

Your email is used only to follow up on this request. We do not add you to marketing lists. Privacy Policy

News: WST

West Pharmaceutical Services, Inc. (WST) Presents at Wells Fargo 21st Annual Healthcare Conference Transcript

seekingalpha.com · 10 Sep 2026

West Pharmaceutical Services, Inc. (WST) Presents at Wells Fargo 21st Annual Healthcare Conference Transcript

West Pharmaceutical Services, Inc. (WST) Presents at Wells Fargo 21st Annual Healthcare Conference Transcript

West Pharmaceutical Services, Inc. $WST Shares Sold by HB Wealth Management LLC

defenseworld.net · 10 Sep 2026

West Pharmaceutical Services, Inc. $WST Shares Sold by HB Wealth Management LLC

HB Wealth Management LLC lowered its stake in shares of West Pharmaceutical Services, Inc. (NYSE: WST) by 28.3% in the second quarter, according to its most recent filing with the Securities and Exchange Commission (SEC). The firm owned 4,709 shares of the medical instruments supplier's stock after selling 1,858 shares during the quarter.

Analyzing West Pharmaceutical Services (NYSE:WST) and Acutus Medical (NASDAQ:AFIB)

defenseworld.net · 4 Sep 2026

Analyzing West Pharmaceutical Services (NYSE:WST) and Acutus Medical (NASDAQ:AFIB)

West Pharmaceutical Services (NYSE: WST - Get Free Report) and Acutus Medical (NASDAQ: AFIB - Get Free Report) are both healthcare companies, but which is the superior business? We will contrast the two companies based on the strength of their analyst recommendations, risk, profitability, earnings, institutional ownership, valuation and dividends. Volatility and Risk West Pharmaceutical Services has

Benjamin Edwards Inc. Grows Position in West Pharmaceutical Services, Inc. $WST

defenseworld.net · 1 Sep 2026

Benjamin Edwards Inc. Grows Position in West Pharmaceutical Services, Inc. $WST

Benjamin Edwards Inc. grew its stake in West Pharmaceutical Services, Inc. (NYSE: WST) by 47.8% in the second quarter, according to the company in its most recent Form 13F filing with the Securities and Exchange Commission. The fund owned 5,322 shares of the medical instruments supplier's stock after buying an additional 1,720 shares

West Pharmaceutical Services, Inc. (NYSE:WST) Receives Average Recommendation of “Moderate Buy” from Brokerages

defenseworld.net · 31 Aug 2026

West Pharmaceutical Services, Inc. (NYSE:WST) Receives Average Recommendation of “Moderate Buy” from Brokerages

West Pharmaceutical Services, Inc. (NYSE: WST - Get Free Report) has earned an average rating of "Moderate Buy" from the fifteen brokerages that are currently covering the firm, MarketBeat.com reports. Three analysts have rated the stock with a hold recommendation, eleven have given a buy recommendation and one has assigned a strong buy recommendation to the

7,730 Shares in West Pharmaceutical Services, Inc. $WST Bought by Caisse de depot et placement du Quebec

defenseworld.net · 30 Aug 2026

7,730 Shares in West Pharmaceutical Services, Inc. $WST Bought by Caisse de depot et placement du Quebec

Caisse de depot et placement du Quebec purchased a new stake in West Pharmaceutical Services, Inc. (NYSE: WST) in the second quarter, according to its most recent Form 13F filing with the Securities and Exchange Commission. The institutional investor purchased 7,730 shares of the medical instruments supplier's stock, valued at approximately $2,775,000. Several

West to Participate in Upcoming Investor Conferences

prnewswire.com · 26 Aug 2026

West to Participate in Upcoming Investor Conferences

EXTON, Pa., Aug. 26, 2026 /PRNewswire/ -- West Pharmaceutical Services, Inc. (NYSE: WST), a global leader in innovative solutions for injectable drug administration, today announced that it will present at the following upcoming investor conferences: Wells Fargo Annual Healthcare Conference on Thursday, September 10, 2026 at 8:45 a.m. EDT in Everett, MA Morgan Stanley Annual Global Healthcare Conference on Monday, September 14, 2026 at 8:30 a.m.

3,700 Shares in West Pharmaceutical Services, Inc. $WST Purchased by Barbara Oil Co.

defenseworld.net · 24 Aug 2026

3,700 Shares in West Pharmaceutical Services, Inc. $WST Purchased by Barbara Oil Co.

Barbara Oil Co. acquired a new stake in shares of West Pharmaceutical Services, Inc. (NYSE: WST) during the undefined quarter, according to its most recent Form 13F filing with the SEC. The institutional investor acquired 3,700 shares of the medical instruments supplier's stock, valued at approximately $1,339,000. Other institutional investors and hedge funds

Similar companies

Disclaimer: The historical data presented on this platform is provided by Financial Modeling Prep. Stock Picker is a platform for informational purposes only and does not provide financial advice. Users are encouraged to conduct their own research and consult with a qualified financial advisor before making investment decisions.